
Treatment of Chronic Paronychia: A Double Blind Comparative Clinical Trial
Using Singly Vaseline, Nystatin and Fucidic Acid Ointment
251
Staph aureus, alpha, beta and gamma-haemolytic Strep-
tococci, Klebsiella pneumonia, Bacteroides species and
Coliform, Pseudomnas aeruginosa, Proteus species and
other organisms as Diphtheroids, Streptococcus fecalis,
and Staphphylococcus albus are considered as secondary
invader in the pathogenesis of chronic paronchia [3].
Hence, the aim of therapy is to close the so-called dead
space and encourage the adhesion of nail cuticle and nail
folds thus preventing the entrance of water, detergents
and bacteria. Therefore, the management of chronic par-
onychia should start by prevention of wet conditions and
giving antimicrobial agents to stop the process of in-
flammation, but unfortunately, many practicing derma-
tologists give antifungal, antibacterial drugs for long time
aiming to enhance cure but without stopping the wet
conditions, so recurrence is always high [2].
Still many housewives do not take the advice of wear-
ing gloves and again will prevent healing of chronic par-
onychia [4].
Accordingly, the aim of present work is to do occlu-
sion of the dead space by Vaseline alone compared with
using antimicrobial agents like fucidic acid and nystatin
and to record the therapeutic response to these therapies.
2. Patients and Methods
This double blind comparative therapeutic trial on the
effectiveness of two drugs topically applied on the nail
folds (nystatin and fucidic acid) compared with Vaseline
on treatment of housewife chronic paronychia. This was
conducted in the Department of Dermatology and Vene-
reology-Baghdad Teaching Hospital, Baghdad, Iraq from
May 2010-May 2011.
Eighty female patients with house wife chronic par-
onychia were enrolled in this study. Inclusion criteria
included all patients with housewife chronic paronychia
who attended for therapy. The diagnosis of chronic par-
onychia was established according to the following crite-
ria: housewife patients, absence of cuticle associated
with swelling and erythema of proximal and lateral nail
folds, separation of dorsal and lateral nail folds from nail
plate. While, exclusion criteria as follow: acute par-
onychia, infections like tinea unguam, warts, and her-
petic whitlow. Also, dermatological diseases that can
cause chronic paronychia such as pemphigus vulgaris,
psoriasis, and lichen planus, connective tissue diseases
like systemic lupus erythematosus, discoid lupus erythe-
matosus, dermatomyositis, and scleroderma were ex-
cluded. Peripheral vascular disease like perniosis, Bur-
ger᾽s disease, Raynaud᾽s disease, patients with immuno-
suppressive conditions, bone deformities, diabetes melli-
tus, and conditions requiring systemic or topical use of
corticosteroids, calcineurin inhibitors, retinoids and pro-
tease inhibitors were not included.
A full history was taken from each patient regarding
name, age, gender, marital status, residence, social status,
job, number of children, using of gloves and washing
machine, right or left hand, baking, smoking. Also dura-
tion, number of fingers involved, and type of treatment
used before.
All patients were examined regarding right or left hand
involvement or both, number of nails involved, presence
of swelling, tenderness, and purulent discharge, presence
of nail changes as buckled nail plates, transverse ridging,
nail discoloration and associated onycholysis or dystro-
phy.
Formal consent was taken from each patient before
starting the trial of treatment after full explanation of
nature of disease, course, prognosis, complications, na-
ture of drug, method of application, duration of treatment
and follow up and the ethical approval was obtained from
Scientific Council of Dermatology and Venereology,
Iraqi Board for Medical Specializations.
Evaluation of the patients was done to re-evaluate the
disease score and report any side effects from treatment
clinically and by photograph during study period of 12
weeks.
All patients were photographed by a digital camera as
a baseline and then on 12 weeks, in the same place with
fixed illumination and distance by using a digital camera
(Sony: Cyber shoot with resolution 12 mega pixels).
The following scoring system of the chronic par-
onychia was invented:
1) Loss of cuticle score = 1
2) Separation of proximal nail fold from nail bed with
different grades and this was measured by orange
stick introduced under the nail folds:
a. Separation just score = 1
b. Separation 2 mm score = 2
c. Separation > 2 mm score = 3
3) Swollen nail fold:
a. Swollen just score = 1
b. Swollen red score = 2
c. Swollen tender score = 3
4) Secondary nail changes:
a. Ridging score = 1
b. Dystrophy score = 3
When patients had multiple fingers involvement, the
severely affected one was scored only and the others al-
though treated they were not counted within scoring.
The treatment protocol: Patients were divided into 3
groups:
Group A: using topical white petrolatum (Vaseline®)
manufactured by Anglo-Dutch Company Unilever.
Group B: using topical nystatin ointment in Vaseline
base (Mycodin®) is manufactured by The State Company
Open Access JCDSA